$30.72
0.42% day before yesterday
NYSE, Jul 03, 09:30 pm CET
ISIN
US2289031005
Symbol
AORT

CryoLife Target price 2025 - Analyst rating & recommendation

CryoLife Classifications & Recommendation:

Buy
92%
Hold
8%

CryoLife Price Target

Target Price $32.64
Price $30.72
Potential
Number of Estimates 9
9 Analysts have issued a price target CryoLife 2026 . The average CryoLife target price is $32.64. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 12 Analysts recommend CryoLife to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CryoLife stock has an average upside potential 2026 of . Most analysts recommend the CryoLife stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 388.54 435.87
9.76% 12.18%
EBITDA Margin 14.25% 20.10%
56.50% 41.07%
Net Margin -3.43% 1.12%
60.24% 132.62%

8 Analysts have issued a sales forecast CryoLife 2025 . The average CryoLife sales estimate is

$436m
Unlock
. This is
11.74% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$451m 15.61%
Unlock
, the lowest is
$415m 6.27%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $389m 9.76%
2025
$436m 12.18%
Unlock
2026
$481m 10.39%
Unlock
2027
$535m 11.28%
Unlock
2028
$607m 13.39%
Unlock
2029
$682m 12.30%
Unlock
2030
$768m 12.69%
Unlock

7 Analysts have issued an CryoLife EBITDA forecast 2025. The average CryoLife EBITDA estimate is

$87.6m
Unlock
. This is
137.03% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$92.3m 149.72%
Unlock
, the lowest is
$82.3m 122.73%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $55.4m 71.77%
2025
$87.6m 58.25%
Unlock
2026
$103m 17.12%
Unlock
2027
$121m 18.15%
Unlock
2028
$153m 25.95%
Unlock
2029
$178m 16.77%
Unlock
2030
$212m 18.82%
Unlock

EBITDA Margin

2024 14.25% 56.50%
2025
20.10% 41.07%
Unlock
2026
21.33% 6.12%
Unlock
2027
22.64% 6.14%
Unlock
2028
25.15% 11.09%
Unlock
2029
26.15% 3.98%
Unlock
2030
27.58% 5.47%
Unlock

8 CryoLife Analysts have issued a net profit forecast 2025. The average CryoLife net profit estimate is

$4.9m
Unlock
. This is
122.75% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$10.3m 148.27%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-13.3m 56.36%
2025
$4.9m 136.43%
Unlock
2026
$19.6m 302.47%
Unlock
2027
$27.4m 40.29%
Unlock
2028
$67.5m 146.03%
Unlock
2029
$85.4m 26.46%
Unlock
2030
$109m 28.05%
Unlock

Net Margin

2024 -3.43% 60.24%
2025
1.12% 132.62%
Unlock
2026
4.06% 262.50%
Unlock
2027
5.12% 26.11%
Unlock
2028
11.12% 117.19%
Unlock
2029
12.52% 12.59%
Unlock
2030
14.23% 13.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.32 0.11
57.33% 134.38%
P/E 269.70
EV/Sales 3.65

8 Analysts have issued a CryoLife forecast for earnings per share. The average CryoLife EPS is

$0.11
Unlock
. This is
121.57% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.24 147.06%
Unlock
, the lowest is
$0.00 100.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.32 57.33%
2025
$0.11 134.38%
Unlock
2026
$0.46 318.18%
Unlock
2027
$0.64 39.13%
Unlock
2028
$1.58 146.88%
Unlock
2029
$2.00 26.58%
Unlock
2030
$2.56 28.00%
Unlock

P/E ratio

Current -60.24 43.64%
2025
269.70 547.74%
Unlock
2026
67.08 75.13%
Unlock
2027
47.81 28.73%
Unlock
2028
19.43 59.36%
Unlock
2029
15.37 20.90%
Unlock
2030
12.00 21.93%
Unlock

Based on analysts' sales estimates for 2025, the CryoLife stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.08 12.40%
2025
3.65 10.45%
Unlock
2026
3.31 9.41%
Unlock
2027
2.97 10.13%
Unlock
2028
2.62 11.81%
Unlock
2029
2.34 10.95%
Unlock
2030
2.07 11.25%
Unlock

P/S ratio

Current 3.36 15.67%
2025
3.01 10.51%
Unlock
2026
2.73 9.41%
Unlock
2027
2.45 10.13%
Unlock
2028
2.16 11.81%
Unlock
2029
1.92 10.95%
Unlock
2030
1.71 11.26%
Unlock

Current CryoLife Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked Jun 17 2025
JMP Securities
Locked
Locked
Locked May 06 2025
Needham
Locked
Locked
Locked May 06 2025
Citizens Capital Markets
Locked
Locked
Locked Feb 25 2025
Needham
Locked
Locked
Locked Feb 25 2025
Stifel
Locked
Locked
Locked Feb 25 2025
Needham
Locked
Locked
Locked Jan 28 2025
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
Jun 17 2025
Locked
JMP Securities:
Locked
Locked
May 06 2025
Locked
Needham:
Locked
Locked
May 06 2025
Locked
Citizens Capital Markets:
Locked
Locked
Feb 25 2025
Locked
Needham:
Locked
Locked
Feb 25 2025
Locked
Stifel:
Locked
Locked
Feb 25 2025
Locked
Needham:
Locked
Locked
Jan 28 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today